Digestive system diseases encompass organic and functional pathologies of the esophagus, gastrointestinal tract, liver, and gallbladder, and are among the most prevalent common and frequently-occurring diseases globally that severely affect patients' quality of life. They are often accompanied by long-term physical suffering such as abdominal pain, acid reflux, and dyspepsia. Some chronic liver diseases and intestinal inflammations are more prone to causing severe systemic complications. With changing lifestyles, the disease burden of metabolic liver diseases and functional gastrointestinal disorders is increasing, and there is an urgent clinical need for innovative drugs and therapies to improve patients' long-term prognosis.
Guangzhou Evidence-Based Medicine collaborates with experts and key opinion leaders in gastroenterology and hepatology to provide full-process solutions from early development strategy to mid-late stage execution, with profound practical expertise in the digestive and liver disease fields.
With a professional and efficient service system and a comprehensive operational network, Guangzhou Evidence Based Medicine is committed to providing tailored one-stop traditional Chinese medicine research and development full industry chain service solutions for every customer, promoting traditional Chinese medicine to the world and safeguarding the health of more people.
